title: Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
authors.affiliation: Department of Surgery, Pathology and Infectious Disease, University of Pittsburgh, PA 15213.
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: M
authors.initials: M
authors.lastname: Green
authors.forename: B
authors.initials: B
authors.lastname: Nour
authors.forename: M
authors.initials: M
authors.lastname: Nalesnik
authors.forename: D
authors.initials: D
authors.lastname: Van Thiel
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: M K
authors.initials: MK
authors.lastname: Breinig
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: M
authors.initials: M
authors.lastname: Cooper
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016031:Liver Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D008297:Male; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D016559:Tacrolimus; D000212:Acyclovir